Advanced search
Publication Cover
Critical Reviews in Biotechnology Volume 36, 2016 - Issue 1
Submit an article Journal homepage
1,112
Views
40
CrossRef citations to date
0
Altmetric
Review Article

Liver cell-targeted delivery of therapeutic molecules

Jeong-Hun KangDivision of Biopharmaceutics and Pharmacokinetics, Department of Biomedical Engineering, National Cerebral and Cardiovascular Center Research Institute, Osaka, Japan, Correspondence[email protected]
,
Riki ToitaDepartment of Biomaterials, Faculty of Dental Science,
&
Masaharu MurataDepartment of Advanced Medical Initiatives, Faculty of Medical Sciences, and ;Innovation Center for Medical Redox Navigation, Kyushu University, Fukuoka, JapanCorrespondence[email protected]
Pages 132-143 | Received 16 May 2013, Accepted 23 May 2014, Published online: 15 Jul 2014

Citations (40)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Vikas Kumar, Mahfoozur Rahman, Prashant Gahtori, Fahad Al-Abbasi, Firoz Anwar & Hyung Sik Kim. (2021) Current status and future directions of hepatocellular carcinoma-targeted nanoparticles and nanomedicine. Expert Opinion on Drug Delivery 18:6, pages 673-694.
Read now
Yu Zhang, Tao Zhou, Li Luo, Zheng Cui, Na Wang, Yamin Shu & Kai-Ping Wang. (2018) Pharmacokinetics, biodistribution and receptor mediated endocytosis of a natural Angelica sinensis polysaccharide. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 254-263.
Read now
Marion Paolini, Laurence Poul, Céline Berjaud, Matthieu Germain, Audrey Darmon, Maxime Bergère, Agnès Pottier, Laurent Levy & Eric Vibert. (2017) Nano-sized cytochrome P450 3A4 inhibitors to block hepatic metabolism of docetaxel. International Journal of Nanomedicine 12, pages 5537-5556.
Read now
Yuexia Xie, Dejun Liu, Chenlei Cai, Xiaojing Chen, Yan Zhou, Liangliang Wu, Yongwei Sun, Huili Dai, Xianming Kong & Peifeng Liu. (2016) Size-dependent cytotoxicity of Fe3O4 nanoparticles induced by biphasic regulation of oxidative stress in different human hepatoma cells. International Journal of Nanomedicine 11, pages 3557-3570.
Read now

Articles from other publishers (36)

Jeong-Hun Kang, Daisuke Asai & Riki Toita. (2023) Bisphenol A (BPA) and Cardiovascular or Cardiometabolic Diseases. Journal of Xenobiotics 13:4, pages 775-810.
Crossref
Ana Margarida Carvalho, Ruchi Bansal, Cristina C. Barrias & Bruno Sarmento. (2023) The Material World of 3D‐Bioprinted and Microfluidic‐Chip Models of Human Liver Fibrosis. Advanced Materials.
Crossref
Cristian Sandoval, Carolina Reyes, Pamela Rosas, Karina Godoy, Vanessa Souza-Mello & Jorge Farías. (2023) Effectiveness of Cerium Oxide Nanoparticles in Non-Alcoholic Fatty Liver Disease Evolution Using In Vivo and In Vitro Studies: A Systematic Review. International Journal of Molecular Sciences 24:21, pages 15728.
Crossref
Xinghui Li, Jiaqi Ni & Li Chen. (2023) Advances in the study of acetaminophen-induced liver injury. Frontiers in Pharmacology 14.
Crossref
Javed & Shikha Yadav. (2023) Advanced therapeutics avenues in hepatocellular carcinoma: a novel paradigm. Medical Oncology 40:8.
Crossref
Joshua E. Porterfield, Rishi Sharma, Ambar Scarlet Jimenez, Nirnath Sah, Sean McCracken, Lucia Zhang, Hyoung‐Tae An, Seulki Lee, Sujatha Kannan, Anjali Sharma & Rangaramanujam M. Kannan. (2023) Galactosylated hydroxyl‐ polyamidoamine dendrimer targets hepatocytes and improves therapeutic outcomes in a severe model of acetaminophen poisoning‐induced liver failure . Bioengineering & Translational Medicine 8:3.
Crossref
Chuansha Gu, Hua Xue, Xiaoli Yang, Yu Nie & Xinlai Qian. (2022) Role of follistatin-like protein 1 in liver diseases. Experimental Biology and Medicine 248:3, pages 193-200.
Crossref
Foteini Athanasopoulou, Michail Manolakakis, Santiago Vernia & Nazila Kamaly. (2023) Nanodrug delivery systems for metabolic chronic liver diseases: advances and perspectives. Nanomedicine 18:1, pages 67-84.
Crossref
Sisi Yang, Chengwei Cai, Huanqiu Wang, Xueqing Ma, Anwen Shao, Jifang Sheng & Chengbo Yu. (2022) Drug delivery strategy in hepatocellular carcinoma therapy. Cell Communication and Signaling 20:1.
Crossref
Yingcheng He, Jianrui Chen, Yanbing Ma & Hongping Chen. (2022) Apolipoproteins: New players in cancers. Frontiers in Pharmacology 13.
Crossref
Feixiang Luo, Ying Yu, Mingqian Li, Yuguo Chen, Peng Zhang, Chunsheng Xiao & Guoyue Lv. (2022) Polymeric nanomedicines for the treatment of hepatic diseases. Journal of Nanobiotechnology 20:1.
Crossref
Jeffrey Barr Warner, Steven Corrigan Guenthner, Josiah Everett Hardesty, Craig James McClain, Dennis Ray Warner & Irina Andreyevna Kirpich. (2022) Liver-specific drug delivery platforms: Applications for the treatment of alcohol-associated liver disease. World Journal of Gastroenterology 28:36, pages 5280-5299.
Crossref
Yayun Peng, Yiyang Cong, Yuzhu Lei, Fanwen Sun, Menghan Xu, Jingzi Zhang, Lei Fang, Hao Hong & Ting Cai. (2022) Transforming Passive into Active: Multimodal Pheophytin‐Based Carbon Dots Customize Protein Corona to Target Metastatic Breast Cancer. Advanced Healthcare Materials 11:8, pages 2102270.
Crossref
Ying Wan, Xuedong Li, Elise Slevin, Kelly Harrison, Tian Li, Yudian Zhang, James E. Klaunig, Chaodong Wu, Ashok K. Shetty, X. Charlie Dong & Fanyin Meng. (2021) Endothelial dysfunction in pathological processes of chronic liver disease during aging. The FASEB Journal 36:1.
Crossref
Seyedeh Alia Moosavian, Thozhukat Sathyapalan, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) The Emerging Role of Nanomedicine in the Management of Nonalcoholic Fatty Liver Disease: A State-of-the-Art Review. Bioinorganic Chemistry and Applications 2021, pages 1-13.
Crossref
Huizhen Sun, Le Chang, Ying Yan & Lunan Wang. (2020) Hepatitis B virus pre‐S region: Clinical implications and applications. Reviews in Medical Virology 31:4.
Crossref
Daniel Fleischmann, Sara Maslanka Figueroa & Achim Goepferich. (2020) Steric Shielding of cRGD-Functionalized Nanoparticles from Premature Exposition to Off-Target Endothelial Cells under a Physiological Flow. ACS Applied Bio Materials 4:1, pages 640-650.
Crossref
Xin Li, Xueling Hu, Tengfei Pan, Lei Dong, Lili Ding, Zhenzhong Wang, Rui Song, Xiuzhu Wang, Ning Wang, Yan Zhang, Jinhui Wang & Baofeng Yang. (2021) Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway. Biomedicine & Pharmacotherapy 133, pages 110802.
Crossref
Natascha Hartl, Friederike Adams & Olivia M. Merkel. (2020) From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier. Advanced Therapeutics 4:1, pages 2000092.
Crossref
Ali Dehshahri, Hossein Sadeghpour, Erfaneh Mohazzabieh, Sara Saatchi Avval & Reza Mohammadinejad. (2020) Targeted double domain nanoplex based on galactosylated polyethylenimine enhanced the delivery of IL ‐12 plasmid . Biotechnology Progress 36:5.
Crossref
Svetlana Yu. Maklakova, Victor A. Naumenko, Andrey D. Chuprov, Maria P. Mazhuga, Nikolai V. Zyk, Elena K. Beloglazkina & Alexander G. Majouga. (2020) Cellular uptake of N-acetyl-d-galactosamine-, N-acetyl-d-glucosamine- and d-mannose-containing fluorescent glycoconjugates investigated by liver intravital microscopy. Carbohydrate Research 489, pages 107928.
Crossref
Yingwen Li, Jingjing Wei, Yaohua Wei, Liang Cheng, Beibei Guo, Fenghua Meng, Feng Li & Zhiyuan Zhong. (2019) Apolipoprotein E Peptide-Guided Disulfide-Cross-Linked Micelles for Targeted Delivery of Sorafenib to Hepatocellular Carcinoma. Biomacromolecules 21:2, pages 716-724.
Crossref
Roland Böttger, Griffin Pauli, Po-Han Chao, Nojoud AL Fayez, Lukas Hohenwarter & Shyh-Dar Li. (2020) Lipid-based nanoparticle technologies for liver targeting. Advanced Drug Delivery Reviews 154-155, pages 79-101.
Crossref
Sue Anne Chew, Stefania Moscato, Sachin George, Bahareh Azimi & Serena Danti. (2019) Liver Cancer: Current and Future Trends Using Biomaterials. Cancers 11:12, pages 2026.
Crossref
Enzo Tramontano, Angela Corona & Luis Menéndez-Arias. (2019) Ribonuclease H, an unexploited target for antiviral intervention against HIV and hepatitis B virus. Antiviral Research 171, pages 104613.
Crossref
Zhe Ma, Bing Zhang, Yuqi Fan, Meng Wang, Dereje Kebebe, Jiawei Li & Zhidong Liu. (2019) Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases. Biomedicine & Pharmacotherapy 117, pages 109128.
Crossref
A-Rang Lee, Kibeom Nam, Byeong Jun Lee, Seoung-Woo Lee, Su-Min Baek, Jun-Sun Bang, Seong-Kyoon Choi, Sang-Joon Park, Tae-Hwan Kim, Kyu-Shik Jeong, Dong Yun Lee & Jin-Kyu Park. (2019) Hepatic Cellular Distribution of Silica Nanoparticles by Surface Energy Modification. International Journal of Molecular Sciences 20:15, pages 3812.
Crossref
Badriya Baig, Sulafa Abdel Halim, Aaminah Farrukh, Yaser Greish & Amr Amin. (2019) Current status of nanomaterial-based treatment for hepatocellular carcinoma. Biomedicine & Pharmacotherapy 116, pages 108852.
Crossref
Mengying Hu & Leaf Huang. (2018) Nanomaterial Manipulation of Immune Microenvironment in the Diseased Liver. Advanced Functional Materials, pages 1805760.
Crossref
Xiaoping Zhang, Lin Zhu, Yaoyong Zhou, Aichao Shi, Hongwu Wang, Meifang Han, Xiaoyang Wan, Semvua Bukheti Kilonzo, Xiaoping Luo, Tao Chen & Qin Ning. (2018) Interference with KCTD9 inhibits NK cell activation and ameliorates fulminant liver failure in mice. BMC Immunology 19:1.
Crossref
Nicholas J. Hunt, Peter A.G. McCourt, David G. Le Couteur & Victoria C. Cogger. (2018) Novel targets for delaying aging: The importance of the liver and advances in drug delivery. Advanced Drug Delivery Reviews 135, pages 39-49.
Crossref
Yuqian Liu, Hsuan-Yao Wang, Li Zhou, Yang Su & Wei-Chiang Shen. (2018) Biodistribution, activation, and retention of proinsulin-transferrin fusion protein in the liver: Mechanism of liver-targeting as an insulin prodrug. Journal of Controlled Release 275, pages 186-191.
Crossref
Riki Toita, Takahito Kawano, Masaharu Murata & Jeong-Hun Kang. (2016) Anti-obesity and anti-inflammatory effects of macrophage-targeted interleukin-10-conjugated liposomes in obese mice. Biomaterials 110, pages 81-88.
Crossref
Wan-Jiang Xue, Ying Feng, Fei Wang, Yi-Bing Guo, Peng Li, Lei Wang, Yi-Fei Liu, Zhi-Wei Wang, Yu-Min Yang & Qin-Sheng Mao. (2016) Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma. Scientific Reports 6:1.
Crossref
SISI JIN, XIANFAN LIN, HUAQIN GUAN & JINMING WU. (2015) Cell-specific expression of the analgesic-antitumor peptide coding sequence under the control of the human α-fetoprotein gene promoter and enhancer. Experimental and Therapeutic Medicine 9:3, pages 863-867.
Crossref
Riki Toita. (2015) Applications of human hepatitis B virus preS domain in bio- and nanotechnology. World Journal of Gastroenterology 21:24, pages 7400.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.